Project title: Trends in incidence and survival outcomes for lung NETs
Claire Mulvey, MD University of California, San Francisco
- Status: Active
- Year(s): 2019
- Grant Type: Mentored
- Research Type: Epidemiological
- Primary Tumor Site: Lung
Mulvey will quantify sociodemographic and geographic patterns of incidence and overall survival among those diagnosed with lung NETs in California from 1992-2017 to identify potential risk factors.
What question will the researchers try to answer?
What is the incidence of lung NETs (typical and atypical histologies) in the diverse state of California from 1992-2017, and what differences might exist in the incidence rate and survival by race, ethnicity, sex, geographic regions, and year of diagnosis?
Why is this important?
Little is known about the epidemiology of lung NETs. This research will yield a better understanding of the predisposing factors, predictors of survival, and disparities in care.
What will researchers do?
Researchers will evaluate whether the incidence patterns and survival differ by patient race/ethnicity, sex, year of diagnosis, and geographic region classified as rural, suburban, or urban.
How might this improve the treatment of NETs?
The data generated from this proposal will provide insight into who gets lung NETs and why, as well as identify opportunities to improve care and to reduce disparities for all patients with lung NETs.
What is the next step?
The data generated from this study will generate hypotheses to inform future etiologic studies and will identify opportunities to improve care for all patients with lung NETs.
- City: San Francisco
- State: CA
- Country: USA
- Grant Duration: 2
NETRF funds laboratory research to understand the development of neuroendocrine tumors and translational research to explore new concepts in treatment. Research grant descriptions and research updates from NETRF are not intended to serve as medical advice. It can take years for research discoveries to be fully validated and approved for patient care. Always consult your health care providers about your treatment options.